Headache after spinal anaesthesia comparing two techniques for treatment of headache following spinal anaesthesia

Efficacy of intranasal sphenopalatine ganglion block by lignocaine spray for the treatment of post dural puncture headache following spinal anaesthesia

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/11/022069

Enrollment

Registered

2019-11-20

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: sphenopalatine ganglion block by lignocaine spray: intanasal spray will be done using an insulin syringe to give treatment - Lignocaine spray 10% and cotton soaked in normal saline Cont

Eligibility

Inclusion criteria

Inclusion criteria: asa assigned class 1 to 3, experiencing a post dural puncture headache within 7 days of dural puncture, patients giving consent to participate, vas score of pain 3 or more than 3, age 18 or more than 18 years

Exclusion criteria

Exclusion criteria: allergy to study medication, <18 years og age, pain score on presentation <3/10 of headache, known nasal septal deviation or abnormalities such as polyp, patients with history of any disorder of nose such as sinusitis, rhinitis

Design outcomes

Primary

Measure	Time frame
efficacy of sphenopalatine ganglion block for the treatment of post dural puncture headache following spinal anaesthesiaTimepoint: Vas score will be assessed at 1/2hr,1hr,2hr,24hr,48hr,72hr and number of blocks required for relief	—

Secondary

Measure	Time frame
adverse effect of sphenopalatine ganglion block, if anyTimepoint: upon discharge patients will be instructed for report when symptoms appear	—

Countries

India

Contacts

Public ContactPRAKASH KUMAR DUBEY

Indira gandhi institute of medical sciences

smitashuchi5@gmail.com8709421084

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026